- categoryName: recent
  categoryData:
    - year: 2025
      conference: British Psychosocial Oncology Society (BPOS) 
      title: Supporting women with breast cancer with adherence to adjuvant endocrine therapy (SWEET): a feasibility study of the HT&Me intervention 
    - year: 2024
      conference: MASCC/AFSO/ISOO (Multinational Association of Supportive Care in Cancer, the Association Francophone des Soins Oncologiques de Support, and the International Society of Oral Oncology) Annual Meeting
      title: Supporting women with breast cancer with adherence to adjuvant endocrine therapy – results from the feasibility study of the HT&Me intervention
    - year: 2024
      conference: Association of Breast Surgery (ABS)
      title: Supporting women with adherence to adjuvant endocrine therapy – results from the SWEET feasibility study 
    - year: 2024
      conference: The UK Interdisciplinary of Breast Cancer Symposium (UKIBCS)
      title: Developing and feasibility testing of an intervention to support women with adherence to adjuvant endocrine therapy and improve quality of life - the SWEET study
    - year: 2023
      conference: International Psycho-oncology Society (IPOS) World Congress of Psycho-Oncology
      title: Development of HT&Me, a blended supported self-management intervention to support adherence to endocrine therapy in women with breast cancer
    - year: 2023
      conference: International Conference on Cancer Nursing
      title: Developing and feasibility testing a self-management endocrine therapy adherence intervention
    - year: 2023
      conference: UK Oncology Nursing Society Conference
      title: The development and feasibility of a nurse-supported self-management intervention for endocrine therapy adherence
    - year: 2023
      conference: Cancer and Primary Care Research International Network (Ca-PRI) Conference
      title: Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
    - year: 2023
      conference: UCL Cancer Symposium
      title: "Supporting women with breast cancer to adhere to adjuvant endocrine therapy: development and optimisation of the HT&Me web-app"
    
- categoryName: archived
  categoryData:
    - year: 2022
      conference: Association of Breast Surgery (ABS)
      title: Supporting women with adherence to endocrine therapy
    - year: 2022
      conference: UK Interdisciplinary of Breast Cancer Symposium (UKIBCS)
      title: "Supporting women with adherence to endocrine therapy following breast cancer: the SWEET Programme"
    - year: 2022
      conference: British Psychological Society (BPS) Division of Health Psychology (DHP) Annual Conference
      title: Exploring the acceptability and usefulness of a digital intervention to support adherence to adjuvant endocrine therapy (AET) in women with breast cancer 
    - year: 2022
      conference: British Psychosocial Oncology Society (BPOS)
      title: Developing and optimising the HT&Me website to support adherence to adjuvant endocrine therapy (AET) in women with breast cancer
    - year: 2022
      conference: UK Society for Behavioural Medicine (UKBSM)
      title: "Supporting women with breast cancer to adhere to hormone therapy: development and optimisation of the HT&Me web-app"
    - year: 2021
      conference: UKONS - Virtual Annual Conference
      title: "Improving outcomes for women diagnosed with early breast cancer through adherence to adjuvant endocrine therapy (SWEET): Developing a digitally based intervention"
    - year: 2021
      conference: Multinational Association of Supportive Care in Cancer Annual Meeting (MASCC)
      title: Improving outcomes for women diagnosed with early breast cancer through adherence to adjuvant endocrine therapy (SWEET) 
    - year: 2021
      conference: International Psycho-oncology Society (IPOS) World Congress of Psycho-Oncology (Virtual)
      title: Improving outcomes for women diagnosed with early breast cancer through adherence to adjuvant endocrine therapy (SWEET) 
    - year: 2021
      conference: Symposium Mammographicum
      title: Supporting women with adherence to adjuvant endocrine therapy following breast cancer (SWEET) 
    - year: 2020
      conference: National Cancer Research Institute (NCRI) Conference
      title: Supporting women with adherence to adjuvant endocrine therapy following breast cancer (SWEET) 
    - year: 2020
      conference: UK Interdisciplinary of Breast Cancer Symposium (UKIBCS)
      title: Improving outcomes for women diagnosed with early breast cancer through adherence to adjuvant endocrine therapy (SWEET) 
